Similar articles for PMID: 29506768

Year	Number of Results
1999	1
2000	1
2001	3
2002	3
2003	1
2004	2
2005	2
2006	2
2007	4
2008	8
2009	8
2010	5
2011	13
2012	17
2013	14
2014	18
2015	17
2016	15
2017	13
2018	10
2019	13
2020	14
2021	5
2022	9
2023	9
2024	0

1

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.

Jin Z, Hartgers ML, Sanhueza CT, Shubert CR, Alberts SR, Truty MJ, Muppa P, Nagorney DM, Smyrk TC, Hassan M, Mahipal A. Jin Z, et al. Eur J Surg Oncol. 2018 May;44(5):677-683. doi: 10.1016/j.ejso.2018.02.008. Epub 2018 Feb 16. Eur J Surg Oncol. 2018. PMID: 29506768

2

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV. Ecker BL, et al. JAMA Surg. 2019 Aug 1;154(8):706-714. doi: 10.1001/jamasurg.2019.1170. JAMA Surg. 2019. PMID: 31141112 Free PMC article.

3

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.

Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet JB, Vaillant JC, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J. Colussi O, et al. Eur J Surg Oncol. 2015 Apr;41(4):520-6. doi: 10.1016/j.ejso.2015.01.010. Epub 2015 Jan 24. Eur J Surg Oncol. 2015. PMID: 25680954

4

The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

Showalter TN, Zhan T, Anne PR, Chervoneva I, Mitchell EP, Yeo CJ, Rosato EL, Kennedy EP, Berger AC. Showalter TN, et al. J Gastrointest Surg. 2011 Aug;15(8):1411-6. doi: 10.1007/s11605-011-1518-6. Epub 2011 Apr 27. J Gastrointest Surg. 2011. PMID: 21523621

5

Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.

Moekotte AL, Malleo G, van Roessel S, Bonds M, Halimi A, Zarantonello L, Napoli N, Dreyer SB, Wellner UF, Bolm L, Mavroeidis VK, Robinson S, Khalil K, Ferraro D, Mortimer MC, Harris S, Al-Sarireh B, Fusai GK, Roberts KJ, Fontana M, White SA, Soonawalla Z, Jamieson NB, Boggi U, Alseidi A, Shablak A, Wilmink JW, Primrose JN, Salvia R, Bassi C, Besselink MG, Abu Hilal M. Moekotte AL, et al. Br J Surg. 2020 Aug;107(9):1171-1182. doi: 10.1002/bjs.11555. Epub 2020 Apr 7. Br J Surg. 2020. PMID: 32259295

6

Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.

Baghmar S, Agrawal N, Kumar G, Bihari C, Patidar Y, Kumar S, Chattopadhyay TK, Panda D, Arora A, Pamecha V. Baghmar S, et al. J Gastrointest Cancer. 2019 Sep;50(3):361-369. doi: 10.1007/s12029-018-0058-7. J Gastrointest Cancer. 2019. PMID: 29464529 Clinical Trial.

7

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Narang AK, Miller RC, Hsu CC, Bhatia S, Pawlik TM, Laheru D, Hruban RH, Zhou J, Winter JM, Haddock MG, Donohue JH, Schulick RD, Wolfgang CL, Cameron JL, Herman JM. Narang AK, et al. Radiat Oncol. 2011 Sep 28;6:126. doi: 10.1186/1748-717X-6-126. Radiat Oncol. 2011. PMID: 21951377 Free PMC article.

8

Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.

Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Krishnan S, et al. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):735-43. doi: 10.1016/j.ijrobp.2007.07.2327. Epub 2007 Nov 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 17980502

9

5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with advanced pancreatic cancer who have progressed on gemcitabine-based therapy.

Lee MG, Lee SH, Lee SJ, Lee YS, Hwang JH, Ryu JK, Kim YT, Kim DU, Woo SM. Lee MG, et al. Chemotherapy. 2013;59(4):273-9. doi: 10.1159/000356158. Epub 2014 Jan 18. Chemotherapy. 2013. PMID: 24457620

10

Ampulla of Vater carcinoma in real-world clinical practice: a case series.

Giuliani J, Piacentini P, Bonetti A. Giuliani J, et al. Tumori. 2015 Jun 25;101(3):e75-8. doi: 10.5301/tj.5000267. Tumori. 2015. PMID: 25908045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year